📚 Immunology Lecture 2 · Innate & Adaptive Immunity ABCT 5101 · 4 Nov 2026
Take immunology apart into parts: who recognises (PAMP/PRR), who enforces (the leukocytes), who remembers (B and T cells), who amplifies (complement), who presents (MHC).
101 · IMM-L2 Lecture 9 · Innate & Adaptive Immunity
Master Logic
- This is the execution layer of immunology: who recognises (PAMP/PRR), who enforces (leukocytes), who remembers (B/T cells), who amplifies (complement), who presents (MHC).
- Two systems, one handover: innate immunity reads fixed patterns and reacts in minutes; adaptive immunity rearranges receptors and remembers for years. Antibodies, complement and MHC are the three places they meet.
- Exam focus: the five PAMPs and their PRRs, the blood-cell differential, the five isotypes, C3/C5 convertases, MHC I vs II peptide length and co-receptors, and the two antigen-processing routes.
A · PAMP: molecules that only the pathogen has
Pathogen-associated molecular patterns (PAMPs) are conserved structures shared by whole classes of microbes but absent from host cells — which is exactly why a fixed set of receptors can recognise them.
| PAMP | Where it comes from | Cognate PRR |
|---|---|---|
| LPS (lipopolysaccharide) | Gram-negative outer membrane | TLR4 |
| Peptidoglycan | Bacterial cell wall | NOD1/NOD2, TLR2 |
| Lipopeptide / lipoteichoic acid | Gram-positive wall | TLR2 |
| CpG DNA | Unmethylated CpG motifs in bacterial DNA | TLR9 |
| Flagellin | Bacterial flagella | TLR5, NLRC4 |
A · PRR: three families of pattern receptors
| Family | Location | Examples | Consequence |
|---|---|---|---|
| TLR (Toll-like) | Plasma membrane or endosome | TLR4 (LPS), TLR5 (flagellin), TLR9 (CpG) | NF-κB → cytokines, co-stimulation |
| NLR (NOD-like) | Cytosol | NOD1/2, NLRP3 | Inflammasome → IL-1β / IL-18 |
| CLR / RLR | Membrane / cytosol | Dectin-1, RIG-I, MDA5 | Fungal and viral sensing |
A · DAMP: the alarm raised by your own damaged cells
Damage-associated molecular patterns are host molecules released when cells die badly — ATP, uric acid crystals, HMGB1, mitochondrial DNA. They bind the same PRRs, so sterile injury can produce inflammation without any pathogen.
B · Haematopoiesis: every immune cell starts in the marrow
Haematopoietic stem cells give two lineages: myeloid (neutrophils, monocytes/macrophages, dendritic cells, eosinophils, basophils, mast cells, red cells, platelets) and lymphoid (B, T, NK). B cells mature in marrow; T cells mature in the thymus.
B · Red cells and granulocytes: the innate workforce
| Cell | Share of leukocytes | Main job |
|---|---|---|
| Neutrophil | 45–75% | Fast phagocytosis and killing; first responder |
| Lymphocyte | 20–45% | Adaptive recognition (B, T, NK) |
| Monocyte | 2–10% | Becomes macrophage or dendritic cell in tissue |
| Eosinophil | 1–6% | Parasites and allergy |
| Basophil | <1% | Histamine release, allergy |
B · Dendritic cell vs macrophage: the phagocytosis ⇄ presentation seesaw
A macrophage is a killer and cleaner: it phagocytoses, destroys, and presents mainly to T cells already in the tissue. A dendritic cell is a courier: it takes up antigen in the periphery, matures while migrating to the lymph node, and presents to naive T cells. Same uptake machinery, opposite priority.
B · NK cells: killing without antigen recognition
NK cells read MHC I: if a cell has lost MHC I (a common viral evasion), the inhibitory signal disappears and the NK cell kills. This is the "missing-self" rule — the opposite logic to T cells, which require MHC.
C · Adaptive immunity: B cells and antibodies
B cells recognise antigen through the BCR (membrane immunoglobulin). Activation is either T-independent (repetitive polysaccharide cross-links the BCR → IgM only, no memory) or T-dependent (protein antigen presented on MHC II to Tfh → class switching, affinity maturation, memory).
C · The four T-cell subsets
| Subset | Core marker | What it does |
|---|---|---|
| TH1 | CD4, IFN-γ | Activates macrophages; intracellular bacteria |
| TH2 | CD4, IL-4/IL-5 | Helminths and allergy; helps B cells make IgE |
| Tc (CTL) | CD8 | Kills infected cells via perforin/granzyme |
| Treg | CD4, FoxP3 | Suppresses; peripheral tolerance |
D · Antibody: structure and Fc functions
Two heavy chains + two light chains. Fab = antigen binding (variable); Fc = effector (constant). Four Fc jobs: opsonisation, complement activation (C1q), ADCC (FcγRIIIa/CD16 on NK), and FcRn recycling (long half-life).
D · The five isotypes
| Isotype | Heavy chain | Where it works | Notes |
|---|---|---|---|
| IgM | μ | Blood, first response | Pentamer; best complement activator |
| IgG | γ | Blood and tissue | Most abundant; crosses placenta |
| IgA | α | Mucosa, milk | Dimer with J chain; secretory component |
| IgE | ε | Mast cells | Type I hypersensitivity; parasites |
| IgD | δ | B-cell surface | Naive B-cell marker |
E · Complement: three routes, two convertases
| Route | Trigger | C3 convertase |
|---|---|---|
| Classical | IgM/IgG bound to antigen → C1q | C4b2b |
| MBL (lectin) | MBL binds mannose on pathogens | C4b2b |
| Alternative | Spontaneous C3 hydrolysis on a surface | C3bBb |
All three make C3 convertase, which deposits C3b and builds C5 convertase; C5 convertase starts the lytic arm.
E · The MAC: from C5 to a hole
C5b → C6 → C7 → C8 → 10–16 × C9 polymerise into a pore. C9 polymerisation is the decisive step; regulators such as CD59 exist only to stop it.
E · Three functions of complement
- Opsonisation (C3b → CR1): phagocytosis.
- Inflammation and chemotaxis (C3a/C5a): vascular leak, neutrophil recruitment.
- Lysis (C5b–C9): direct membrane damage.
F · MHC: a mouse in 1948
Snell's transplantation experiments showed that rejection follows a genetic locus — the major histocompatibility complex. Same-strain grafts survive; different-strain grafts are rejected. The locus turned out to be the peptide-display system.
F · MHC I vs MHC II
| MHC I | MHC II | |
|---|---|---|
| Chains | α + β2-microglobulin | α + β |
| Expressed on | All nucleated cells | APCs only (DC, macrophage, B) |
| Peptide | 8–9 aa | 13–18 aa |
| Presents to | CD8 | CD4 |
| Source | Endogenous (cytosol) | Exogenous (endosome) |
F · MHC I structure
α1 and α2 form the peptide-binding groove, closed at both ends — hence the short peptide. α3 binds CD8; β2-microglobulin stabilises the whole molecule.
F · MHC II structure
α1 and β1 form an open groove, so longer peptides overhang. β2 binds CD4. Expression is restricted to APCs and is induced by IFN-γ.
F · Antigen processing: two routes
| Cytosolic → MHC I | Endocytic → MHC II | |
|---|---|---|
| Degradation | Proteasome | Endosomal/lysosomal proteases |
| Transport | TAP into ER | No TAP |
| Assembly | MHC I + peptide in ER | Invariant chain → CLIP → HLA-DM exchange |
| Result | CD8 sees viral peptides | CD4 sees phagocytosed material |
F · MHC I and the CD8 "MHC check"
The CD8 co-receptor binds the α3 domain of MHC I. Only when the TCR sees MHC I plus peptide does CD8-positive T cells get signal 1; without MHC, nothing happens — which is why viruses down-regulate MHC I, and why NK cells watch for that loss.
F · MHC II and the CD4 "MHC check"
CD4 binds the β2 domain of MHC II. This is the physical basis of the "CD4 helper" rule: helper T cells can only be activated by an APC displaying MHC II.
Key Terms
| Term | Meaning |
|---|---|
| PAMP / DAMP | Pathogen- or damage-associated molecular pattern |
| PRR | Pattern-recognition receptor (TLR, NLR, CLR/RLR) |
| ADCC | Antibody-dependent cellular cytotoxicity (NK via CD16) |
| Opsonisation | Coating a pathogen with antibody or C3b to increase phagocytosis |
| Isotype | Antibody class defined by the heavy-chain constant region |
| Convertase | C3 convertase (C4bC2b or C3bBb); C5 convertase adds a C3b |
| MAC | Membrane attack complex: C5b + C6–C8 + (10–16) C9 |
| MHC | Major histocompatibility complex; class I to CD8, class II to CD4 |
| TAP | Transporter that pumps peptides into the ER for MHC I |
| CLIP / Ii chain | Invariant chain protects MHC II until HLA-DM swaps in peptide |
Page-by-page details from the handwritten Lecture 9 notes
These numbers and mechanisms come from re-reading all 59 handwritten pages. They are what the original note missed or had only as a name — and multiple-choice questions love distinguishable numbers.
1 · The five PAMPs and where they sit (p2)
| PAMP | Location | Note |
|---|---|---|
| LPS | Outer membrane of Gram-negative bacteria | TLR4 |
| Peptidoglycan | Cell wall of Gram-positive (major) and Gram-negative | TLR2 / NOD |
| Lipopeptide | Plasma membrane surface of bacteria | TLR2 / TLR6 |
| Unmethylated CpG DNA | CpG motif in bacterial/viral DNA | TLR9 |
| Flagellin | Structural protein of bacterial flagella | TLR5 |
2 · Five characteristics of PAMPs (p3)
- Found only in microbes / pathogens (bacteria, viruses, fungi).
- Conserved molecular structures, on the surface or inside the pathogen.
- Essential for pathogen survival — so they cannot easily mutate away.
- Absent from human cells → the immune system can tell self from non-self.
- Recognised by PRRs → triggers innate immunity.
3 · Three types of PRR (p4–p9)
| Type | Location | Examples | Job |
|---|---|---|---|
| Type I | Extracellular (membrane) | TLR, mannose receptor, C-type lectin receptor | Catch extracellular pathogens |
| Type II | Secreted / soluble | Complement receptors | ① enhance phagocytosis (opsonisation) ② activate the complement cascade |
| Type III | Intracellular (cytosol) | NOD-like receptors (nucleotide-binding oligomerization domain) | Sense intracellular pathogens; amplify the response |
Five TLR facts: first found in Drosophila; recognise PAMPs and DAMPs; mainly defend against bacteria, viruses, fungi; activate signalling → cytokines / chemokines; humans have 10 types.
| TLR | Ligand |
|---|---|
| TLR3, 7, 8 | RNA (viral) |
| TLR9 | Unmethylated CpG DNA |
| TLR4 | LPS (Gram-negative) |
| TLR2, 6 | Lipopeptide |
| TLR5 | Flagellin |
4 · The “distinguishable numbers” of leukocytes (p13–p24)
| Cell | % of WBC | Lifespan | Nucleus | Key function |
|---|---|---|---|---|
| Neutrophil | 45–75% | 1–2 days in tissue | Multi-lobed (2–5) | First responder; professional phagocyte; antimicrobial peptides; degranulation; pro-inflammatory cytokines |
| Eosinophil | 2–4% | 8–12 h in blood, days in tissue | Bi/tri-lobed | Allergy (asthma, eczema), parasites; histamine; degranulation |
| Basophil | <1% | 1–3 days | Bi/tri-lobed | IgE-mediated allergy; histamine; cytokines |
| Monocyte | 2–8% | 1–3 days | Kidney-shaped | Becomes macrophage / DC; phagocytosis; cytokines, chemokines |
| Mast cell | — (tissue) | Weeks | — | Mucosa / epithelium / connective tissue; IgE allergy, inflammation, parasites |
| NK | — | — | — | Kills infected / cancer cells; ADCC; cytokines that activate macrophages |
5 · DC maturation: from eating to showing (p25–p26)
| Stage | What it does |
|---|---|
| Immature DC | Samples the tissue by phagocytosis; detects PAMP / DAMP |
| Mature DC | ① cytoskeleton reorganisation ② increased motility ③ decreased phagocytic activity → switches to antigen presentation and carries antigen to T cells |
One line: immature DC is a sampler, mature DC is a courier — same cell, reversed job.
6 · Macrophages get tissue names (p27)
Once in tissue: CNS → microglia; skin → Langerhans cells. Exams often give the tissue name and expect you to know it is a macrophage.
7 · How much antibody a plasma cell makes (p29)
An activated B cell becomes a plasma cell secreting hundreds to thousands of antibodies per second. That number is how you tell a B cell (recogniser) from a plasma cell (factory).
8 · Th1's full job list (p30)
- Regulates the response to intracellular pathogens (viruses, bacteria).
- Secretes cytokines that activate macrophages (IFN-γ), activate CD8 (IL-2) and induce NK cytotoxicity.
- Participates in inflammation.
Lecture 9 supplement (part 2): the five isotypes, Fc functions, three T subsets
9 · The numbers that distinguish the five isotypes (p37–p41)
| Isotype | Heavy chain | Structure | % of serum Ig | Half-life | Key function |
|---|---|---|---|---|---|
| IgG | γ | Monomer | ~80% | 21–23 days | Classical complement, ADCC (NK), opsonisation, toxin neutralisation, placental transfer (neonatal immunity) |
| IgA | α | Monomer ~80% / dimer ~20% | 10–15% | 5–6 days | Secretory IgA transported across mucosa; tears, breast milk, saliva; local mucosal immunity |
| IgM | μ | Pentamer | ~5–10% | ~5 days | Primary response; strongest complement activation (several Fc at once) |
| IgD | δ | Monomer | ~1% | ~3 days | B-cell surface; B-cell activation; allergy |
| IgE | ε | Monomer | very low | ~2 days (longer once bound) | Mast cells / basophils; type I hypersensitivity; parasites |
| Isotype | Subclasses | Proportions |
|---|---|---|
| IgG | IgG1 / IgG2 / IgG3 / IgG4 | 70% / 20% / 8% / 2% |
| IgA | IgA1 / IgA2 | — |
| IgM, IgE, IgD | no subclasses | — |
10 · The four effector jobs of Fc (p35–p36)
| Job | Mechanism |
|---|---|
| Complement activation | Once Fc is bound to pathogen, C1q recognises Fc → classical pathway |
| Inflammation | Fc binds immune cells (e.g. mast cells) → mediator release |
| Opsonisation | Coating the pathogen with antibody increases phagocytic uptake |
| ADCC | Antibody-dependent cell-mediated cytotoxicity: NK cells recognise antibody-coated targets via Fc receptors and kill them |
Fab vs Fc: Fab is the NH₂-terminal variable part and binds antigen; Fc is the COOH-terminal constant part and does the effector work. Heavy and light chains are held by disulfide bonds.
11 · What each T subset actually does (p30–p33)
| Subset | Marker | Job |
|---|---|---|
| Th1 | CD4, CCR5 | Intracellular pathogens; IFN-γ activates macrophages; IL-2 activates CD8; induces NK; inflammation |
| Th2 | CD4, CCR3 | Extracellular pathogens / parasites; IL-4 and IL-5 → activate B cells to make antibody; IL-10 is anti-inflammatory; recruits and activates eosinophils |
| Tc (CTL) | CD8 | Cell-mediated immunity; kills infected/abnormal cells in an antigen-specific way; induces apoptosis; kills only the target, not neighbouring tissue |
| Treg | CD4⁺CD25⁺FoxP3⁺ | Maintains self-tolerance, prevents autoimmunity; suppresses over-active CD4/CD8; controls inflammation; maintains tolerance to commensal microbiota |
12 · Antibody specificity in one line (p34)
Different B cells are responsible for different pathogens, and each antibody binds only its matching antigen. Specificity is not “strength” — it is a one-to-one pairing.
中文邏輯:先天免疫用固定 PAMP/PRR 快速反應,適應性免疫用重排受體精準記憶;抗體、補體、MHC 就是兩層之間的接駁位。